Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Sales | 65 | 74 |
| Cost of Goods | 6,445 | 5,632 |
| Gross Profit | -6,380 | -5,558 |
| Operating Expenses | 2,477 | 1,839 |
| Operating Income | -8,857 | -7,397 |
| Interest Expense | 111 | 169 |
| Other Income | 11 | 8 |
| Pre-tax Income | -8,957 | -7,558 |
| Income Tax | -1,561 | -1,665 |
| Net Income Continuous | -7,396 | -5,893 |
| Net Income Extraordinary | -704 | 0 |
| Net Income | $-8,099 | $-5,894 |
| EPS Basic Total Ops | -0.87 | -0.64 |
| EPS Diluted Total Ops | -0.87 | -0.64 |
| EBITDA(a) | $-8,698 | $-7,374 |